… An accurate characterization of the immune pathways involved in psoriasis led to recognize
the new molecules, (IL)17 and 23, which become the new target of biologic therapy for …

… and other biological data in well-phenotyped patients who are commencing a new biologic
therapy. It is … Old and new biological therapies for psoriasis. Int J Mol Sci 2017; 18: 1–23. 66. …

… The introduction of a plethora of biologic drugs has transformed patient outcomes such
that skin clearance is now a realistic treatment goal. Psoriasis biologic drugs target tumour …

… Citation32 Moreover, TNF-α and IL-17 inhibitors represent a first line biological treatment
for psoriatic arthritis, particularly in case of involvement of the axial, tendons and entheses …

… with biologic therapy for psoriasis in terms of both the safety and efficacy of these agents. This
new treatment … advancing knowledge of the pathophysiology of psoriasis. Thirty years ago, …

… initiating biological treatment of 61.3–67.6% if an increase in age of 30 years is assessed
[Citation11]. Hence, more evidence around treatment strategy for moderate-to-severe psoriasis …

… biological therapy. Therefore, it is imperative to understand major benefits and limitations of
each biological therapy… choice of biological therapy for psoriasis patients with specific needs. …

… To date, our study represents the widest experience on the use of biological drugs in elderly
psoriatic patients. We found that all biologics for psoriasis showed a great efficacy also in …

… treatment failure with related huge health costs and reduced patients’ quality of life. Herein
… present and discuss the recent advances in personalized biological treatment for psoriasis. …

… Psoriasis is a chronic inflammatory skin disease that affects 2–4% of individuals worldwide,
… pathogenesis of psoriasis has led to the introduction of powerful targeted biologic therapies, …